XWELL, Inc.

Name: XWELL, Inc. standardized financial statements, quarterly
Creator: Listed

XWELNasdaqCIK 1410428IndustrialsFiscal year ends Dec 31

Share this page

Link

Story card, 1080 × 1920

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$7.1m, Q2 FY2026

Operating income−$2.1m, Q2 FY2026

Net income−$2.2m, Q2 FY2026

XWELL, Inc., income statement, quarterly
Line item	Unit	Q3 FY20232023-09-30	Q4 FY20232023-12-31	Q1 FY20242024-03-31	Q2 FY20242024-06-30	Q3 FY20242024-09-30	Q4 FY20242024-12-31	Q1 FY20252025-03-31	Q2 FY20252025-06-30	Q3 FY20252025-09-30	Q4 FY20252025-12-31	Q1 FY20262026-03-31	Q2 FY20262026-06-30
Revenue	$m	7.5	7.4	8.7	9.3	8.4	7.5	7.0	7.7	7.3	7.2	6.6	7.1
Cost of revenue	$m	6.4	6.5	6.1	6.2	6.4	6.3	5.7	5.9	5.9	4.2	4.3	4.2
Gross profit	$m	1.1	0.9	2.7	3.1	2.1	1.1	1.3	1.8	1.5	2.9	2.4	2.9
Research and development	$m	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported
Selling, general and administrative	$m	3.0	2.7	4.2	4.7	6.4	4.8	4.3	4.3	1.6	5.9	7.6	4.7
Operating income	$m	(12.1)	(5.1)	(2.4)	(1.9)	(4.8)	(7.7)	(3.2)	(2.7)	(0.8)	(9.1)	(5.4)	(2.1)
Interest expense	$m	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported
Income tax	$m	not reported	not reported	not reported	not reported	not reported	not reported	not reported	0.0	0.0	(0.0)	not reported	0.1
Net income	$m	(11.5)	(5.0)	(2.5)	(2.0)	(4.8)	(7.6)	(4.7)	(2.3)	(0.7)	(9.3)	(11.2)	(2.2)
Diluted EPS	$ per share	(2.76)	not reported	(0.60)	(0.48)	(0.99)	not reported	(1.00)	(0.56)	(0.26)	not reported	(1.51)	(0.26)
Basic EPS	$ per share	(2.76)	not reported	(0.60)	(0.48)	(0.99)	not reported	(1.00)	(0.56)	(0.26)	not reported	(1.51)	(0.26)

Balance sheet

Cash and equivalents$11.8m, Q2 FY2026

Shareholders' equity−$1.9m, Q2 FY2026

XWELL, Inc., balance sheet, quarterly
Line item	Unit	Q3 FY20232023-09-30	FY20232023-12-31	Q1 FY20242024-03-31	Q2 FY20242024-06-30	Q3 FY20242024-09-30	FY20242024-12-31	Q1 FY20252025-03-31	Q2 FY20252025-06-30	Q3 FY20252025-09-30	FY20252025-12-31	Q1 FY20262026-03-31	Q2 FY20262026-06-30
Cash and equivalents	$m	4.8	8.4	4.3	5.4	4.4	4.6	3.7	5.3	4.0	2.6	16.8	11.8
Current assets	$m	30.0	26.6	24.5	23.1	19.5	15.3	14.8	11.8	10.8	5.9	19.7	15.1
Total assets	$m	42.9	39.0	37.5	36.3	33.8	25.4	24.8	22.4	21.7	11.2	25.0	20.5
Current liabilities	$m	8.2	9.3	9.2	10.4	9.9	9.2	8.9	9.5	10.1	12.9	8.4	6.7
Total liabilities	$m	17.3	18.0	18.7	19.1	19.0	17.6	21.4	18.3	18.3	23.8	14.9	12.3
Long-term debt	$m	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported
Current portion of debt	$m	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported
Shareholders' equity	$m	17.8	13.0	10.6	8.8	6.3	(0.8)	(5.8)	(5.2)	(6.3)	(22.3)	0.4	(1.9)

Cash flow

Operating cash flow−$4.5m, Q2 FY2026

Capital expenditure$169.0k, Q2 FY2026

XWELL, Inc., cash flow, quarterly
Line item	Unit	Q3 FY20232023-09-30	Q4 FY20232023-12-31	Q1 FY20242024-03-31	Q2 FY20242024-06-30	Q3 FY20242024-09-30	Q4 FY20242024-12-31	Q1 FY20252025-03-31	Q2 FY20252025-06-30	Q3 FY20252025-09-30	Q4 FY20252025-12-31	Q1 FY20262026-03-31	Q2 FY20262026-06-30
Operating cash flow	$k	(4,255)	(3,201)	(3,682)	(443)	(3,416)	(3,464)	(4,178)	(2,386)	(2,107)	(42.0)	(4,602)	(4,515)
Capital expenditure	$k	404	266	291	353	410	729	424	889	945	706	390	169
Share repurchases	$k	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported

Diluted shares (weighted)8.49m, Q2 FY2026

XWELL, Inc., shares, quarterly
Line item	Unit	Q3 FY20222022-09-30	Q1 FY20232023-03-31	Q2 FY20232023-06-30	Q3 FY20232023-09-30	Q1 FY20242024-03-31	Q2 FY20242024-06-30	Q3 FY20242024-09-30	Q1 FY20252025-03-31	Q2 FY20252025-06-30	Q3 FY20252025-09-30	Q1 FY20262026-03-31	Q2 FY20262026-06-30
Diluted shares (weighted)	k shares	4,731	4,167	4,171	4,174	4,183	4,183	4,819	5,261	5,417	5,761	7,396	8,487

Shares outstanding: 8.59m at Aug 10, 2026, from the cover of the 10-Q filed Aug 14, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:39 ET. Listed shows no prices and gives no investment advice.